R&D

Research & Development Pipeline

Area Asset/ Partner   Indication Development Pre-clinical Clinical Regulatory Submission Approved²

Oncology

Anagrelide

Solid tumours with increased platelet levels

 

Central Nervous System

ZolpiMist™ ¹

Insomnia

 

Sumatriptan

Migraine

 

Medical Grade Cannabis

Zelira Therapeutics

Not disclosed

 

Cann Pharma

Drug resistant epilepsy, melonoma, motion sickness

 

Development Partnership

Ordesa

Not disclosed

 

Sanofi

Not disclosed

 
¹Suda holds the license to ZolpMist outside of North America
²ZolpMist has been approved by the TGA & the FDA